Pfizer’s $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.
Source: Trillium Therapeutics shares soar on Pfizer’s $2.26B deal | Fox Business
News Of Western Pennsylvania And The World
Pfizer’s $2.26B Trillium deal will target drugs for blood cancers, such as leukemia, multiple myeloma and lymphoma, according to the companies.
Source: Trillium Therapeutics shares soar on Pfizer’s $2.26B deal | Fox Business